Skip to content
10-Q

Quarterly Report

Bio-En Holdings Corp.

0001104659-21-106214

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 30, 2021 77.35M sh
Cash And Equivalents Q2 2021 · Jun 30, 2021 $19.68K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $11.71K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $270
Cash And Equivalents Q2 2021 · Dec 31, 2019 $420
Stockholders Equity Q2 2021 · Jun 30, 2021 −$454.79K
Stockholders Equity Q2 2021 · Dec 31, 2020 −$442.78K
Current Liabilities Q2 2021 · Jun 30, 2021 $474.47K
Current Liabilities Q2 2021 · Dec 31, 2020 $469.49K
Total Liabilities Q2 2021 · Jun 30, 2021 $474.47K
Total Liabilities Q2 2021 · Dec 31, 2020 $469.49K
Current Assets Q2 2021 · Jun 30, 2021 $19.68K
Current Assets Q2 2021 · Dec 31, 2020 $26.71K
Total Assets Q2 2021 · Jun 30, 2021 $19.68K
Total Assets Q2 2021 · Dec 31, 2020 $26.71K
Operating Income Q2 2021 · Jun 30, 2021 $13.64K
Operating Income restated Q2 2021 · Jun 30, 2020 $15.56K
Operating Income restated Q2 2021 · Jun 30, 2020 $34.94K
Revenue Q2 2021 · Jun 30, 2021 $0
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$235.15K
Net Income Q2 2021 · Jun 30, 2020 −$15.56K
Net Income Q2 2021 · Jun 30, 2020 −$269.94K